- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03988777
Magnetic Seed Localisation for Nonpalpable Breast Lesions
June 14, 2019 updated by: Universitaire Ziekenhuizen KU Leuven
Magnetic Seed Localisation for Nonpalpable Breast Lesions: a Combined Retrospective and Prospective Analysis
Screening programs and advances in imaging have led to more breast lesions being diagnosed at an impalpable stage.
Multiple localisation techniques for nonpalpable breast lesions have been developed during the past decades.
Specifically, several alternatives to the golden standard hooked-wire technique have become available, of which magnetic seed localisation is one of the newest approaches.
Since September 2018, Magseed® localisation is the standard of care for localising impalpable breast lesions in UZ Leuven.
In this study, the oncological safety, the clinical safety and surgeon satisfaction of Magseed® localisation will be assessed and retrospectively compared to hooked-wire localisation.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
192
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Leuven, Belgium, 3000
- University Hospitals Leuven
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
Study population includes women (18+) with an impalpable breast lesion suitable for breast conserving surgery.
Description
Inclusion Criteria:
- Breast conserving surgery with preoperative localisation
- Minimum 18 years old
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Other
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Prospective Magseed
This cohort includes patients with an impalpable breast lesion that are scheduled for breast conserving surgery with Magseed localisation after September 2018.
Their data will be prospectively collected and analysed.
|
Impalpable breast lesions are preoperatively localised, either with hooked-wire (retrospective study) or Magseed (prospective study)
|
|
Retrospective hooked-wire
This cohort includes patients with an impalpable breast lesion that were scheduled for breast conserving surgery with hooked-wire before September 2018.
Their data will be retrospectively collected and analysed.
|
Impalpable breast lesions are preoperatively localised, either with hooked-wire (retrospective study) or Magseed (prospective study)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of participant with device-related adverse events
Time Frame: Up to three weeks after surgical treatment
|
Up to three weeks after surgical treatment
|
|
|
Total breast volume resected during breast conserving surgery
Time Frame: Up to three weeks after surgical treatment
|
Up to three weeks after surgical treatment
|
|
|
Number of participants with positive surgical margins as assessed by pathological examination of the specimen
Time Frame: Up to three weeks after surgical treatment
|
Up to three weeks after surgical treatment
|
|
|
Re-operation rate due to positive surgical margins
Time Frame: Up to three weeks after surgical treatment
|
Up to three weeks after surgical treatment
|
|
|
Surgeon satisfaction based on a questionnaire
Time Frame: After surgery
|
After surgery, the surgeon will be asked to describe the magnetic seed procedure, choosing between 'easier than hooked-wire' or 'more challenging than hooked-wire'.
Moreover, the surgeon wil have the chance to add additional remarks or experiences with this new technique.
|
After surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 10, 2018
Primary Completion (Actual)
March 29, 2019
Study Completion (Actual)
May 23, 2019
Study Registration Dates
First Submitted
May 29, 2019
First Submitted That Met QC Criteria
June 14, 2019
First Posted (Actual)
June 17, 2019
Study Record Updates
Last Update Posted (Actual)
June 17, 2019
Last Update Submitted That Met QC Criteria
June 14, 2019
Last Verified
May 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- S61864
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.